April 2018 Issue
CE & Training
An oral solution formulation for C. difficile-associated diarrhea and enterocolitis caused by S. aureus (including MRSA).
A "follow-on" rapid-acting insulin analog for diabetes.
New oral solution formulation for pediatric patients with acute lymphoblastic leukemia (ALL) and juvenile arthritis.